These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14482194)

  • 1. [Clinical experience in otorhinolaryngology with a new synthetic antiphlogistic drug].
    ORECCHIONI F
    Ann Laringol Otol Rinol Faringol; 1962; 61():236-43. PubMed ID: 14482194
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the use and antiphlogistic therapeutic effectiveness of a metabolite of phenylbutazone in some disease processes of otorhinolaryngoiatric interest].
    PAROLARI P
    Otorinolaringol Ital; 1961 Dec; 30():462-6. PubMed ID: 14484015
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the action of a new anti-inflammatory agent G 27202 in otorhinolaryngology].
    ROSSERT A
    Gaz Med Fr; 1961 Sep; 68():1927-31. PubMed ID: 13743681
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with oxyphenylbutazone in otorhinolaryngoiatric practice].
    RIZZI N
    Gazz Med Ital; 1962 Jan; 121():18-21. PubMed ID: 14492634
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinicoexperimental investigations with oxyphenylbutazone in otorhinolaryngology].
    DE VINCENTIIS I; CROCE G; SIMONCELLI C
    Boll Mal Orecch Gola Naso; 1962; 80():160-73. PubMed ID: 13884584
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of a new anti-inflammatory drug in the ORL and maxillofacial domains].
    VINCENT P
    Toulouse Med; 1962 Feb; 63():153-62. PubMed ID: 13926084
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experience in treatment with the antipyretic drug Tanderil in otorhinolaryngology].
    NAKAMURA F; MIZUGOSHI O; ODA M; KONO Y; SUGAHARA M; NAKAMURA A; YAMASHITA M; IMURA H
    Jibiinkoka; 1962 Sep; 34():791-5. PubMed ID: 13937384
    [No Abstract]   [Full Text] [Related]  

  • 8. [G 27,202 in O.R.L. surgery].
    ANDRE P; FREYSS G
    Ann Otolaryngol; 1962 Jun; 79():454-59. PubMed ID: 13861383
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience in the use of Tanderil in otorhinolaryngology].
    FUKUDA E; TOMURA T; TAIRA H
    Jibiinkoka; 1962 Sep; 34():787-9. PubMed ID: 13960165
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experience with the use of a new antiphlogistic agent in urology].
    LEONETTI P
    Minerva Urol; 1962; 14():88-9. PubMed ID: 14464112
    [No Abstract]   [Full Text] [Related]  

  • 11. [New antiphlogistic drugs: G-27202].
    TREZZINI C
    Clin Ter; 1962 Jul; 23():57-63. PubMed ID: 13922446
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of a new antiphlogistic agent on capillary permeability].
    MASTROJENI D; CAMBRIA S
    Gazz Int Med Chir; 1962 Jul; 66():1591-9. PubMed ID: 14470998
    [No Abstract]   [Full Text] [Related]  

  • 13. [The binding of the antiphlogistic agent phydroxyphenylbutazone to serum proteins].
    WUNDERLY C
    Arzneimittelforschung; 1960 Nov; 10():910-1. PubMed ID: 13786916
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the clinical trial of the new antiphlogistic drug G 27,202 in tonsillectomy].
    CANCURA W
    Ther Umsch; 1960 Sep; 17():314-5. PubMed ID: 13690373
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with the antiphlogistic drug G 27,202].
    BARCZYK W; ROETH G
    Praxis; 1960 Jun; 49():589-91. PubMed ID: 13796682
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiphlogistic effects of new antirheumatic drugs. Clinical observation].
    CARNEIRO RA
    Hospital (Rio J); 1961 Dec; 60():965-73. PubMed ID: 13876705
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical results on the application of the new antiphlogistic preparation, G-27202 (Tanderil) in ocular diseases].
    CHINAGLIA V; CREPALDI A
    Ann Ottalmol Clin Ocul; 1961 Oct; 87():529-39. PubMed ID: 13878997
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical test of the antiphlogistic properties of Tanderil following phimosis operations].
    DITTRICH H; SCHARF H
    Med Welt; 1961 Aug; 34():1710-1. PubMed ID: 13723111
    [No Abstract]   [Full Text] [Related]  

  • 19. [Toxicity and antiphlogistic effects of 4-(3-chloro-3-buteny1)-1,2-diphenyl-3,5-pyrazolidinedione].
    LENFELD J; KROUTIL M; BOCEK M; CTVRTNIK J; MAYER J
    Arzneimittelforschung; 1961 Apr; 11():427-9. PubMed ID: 13760809
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the antiphlogistic agent G 27202 (Tanderil)].
    von RECHENBERG H; HERRMANN B
    Schweiz Med Wochenschr; 1961 Apr; 91():403-5. PubMed ID: 13740155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.